Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 79,600 shares (grant or award)
  3. 4 Grant or award Director acquired 73,600 shares (grant or award)
  4. 4 Grant or award Director acquired 96,000 shares (grant or award)
  5. 4 Grant or award Director acquired 70,000 shares (grant or award)
  6. 4 Grant or award Director acquired 79,200 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy President and CEO bought 685 shares at $1.46 ($1,000)
  10. 4 Open-market buy President and CEO bought 694 shares at $1.44 ($999)
  11. 4 Open-market buy President and CEO bought 719 shares at $1.39 ($999)
  12. 4 Option exercise 10% owner acquired 1,941,770 shares (option exercise)
  13. 4 Option exercise 10% owner acquired 773,003 shares (option exercise)
  14. 4 Option exercise 10% owner acquired 583,333 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy President and CEO bought 768 shares at $1.30 ($998)
  19. 4 Open-market buy President and CEO bought 555 shares at $1.80 ($999)
  20. 4 Derivatives Options or other derivatives

Page 13 of 28 · 551 filings